StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Neurocrine Biosciences, Inc.
NasdaqGS:NBIX
Sector
Location
Market Cap
USD 13.03 B
Share Price
USD 131.64
Avg Daily Volume
1,322,248
Change (1 day)
-1.51%
Change (1 year)
-9.76%
Change (YTD)
-3.56%
Neurocrine Biosciences, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 10.44
Neurocrine Biosciences, Inc. Interest Coverage Ratio is 10.44 for the Trailing 12 Months (TTM) ending March 31, 2025, a -89.79% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
-
Neurocrine Biosciences, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 102.26, a 743.39% change year over year.
-
Neurocrine Biosciences, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 12.12, a 146.53% change year over year.
-
Neurocrine Biosciences, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 4.92, a -14.01% change year over year.
-
Neurocrine Biosciences, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 5.72, a -21.28% change year over year.
Competitors
Eli Lilly and Company
USD 805.43
LLY
+6.54
0.82%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
CSL Limited
USD 177.62
CSL.AX
+2.36
1.34%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
MERCK Kommanditgesellschaft auf Aktien
USD 133.12
MRK.DE
+0.98
0.74%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Key Data
| Date | Interest Coverage Ratio | Return on Capital Employed (ROCE) | Return on Equity (ROE) | Return on Assets (ROA) |
|---|
Competitors
Eli Lilly and Company
USD 805.43
LLY
+6.54
0.82%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
CSL Limited
USD 177.62
CSL.AX
+2.36
1.34%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
MERCK Kommanditgesellschaft auf Aktien
USD 133.12
MRK.DE
+0.98
0.74%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%